. . . . . "2021-12-16T19:34:23.681956"^^ . "S&T TWOC project version 2" . "2"^^ . "with lenalidomide and dexamethasone alone ( Rd )" . "35"^^ . "compared" . "[221]" . "lenalidomide and dexamethasone ( DRd ) significantly prolonged progression-free survival in transplant-ineligible patients with newly diagnosed multiple myeloma" . "52"^^ . "6bnj8pcp" . "PURPOSE The MAIA trial found that addition of daratumumab to lenalidomide and dexamethasone (DRd) significantly prolonged progression-free survival in transplant-ineligible patients with newly diagnosed multiple myeloma, compared with lenalidomide and dexamethasone alone (Rd)." . "6bnj8pcp-TRIPLE-ABSTRACT-5" . "alone" . "prolonged" . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" . "S/gKcZuuMj1qKyPQHEjXrQK3QL4cwMXLAOekM9FPcBtfLq1YvPut5u8UaAKxZ88PBi1exZqei9WraeX7xgWNHfj8uKFsGxdhSy2j5z4GoEJUomJZAV4Dapveb3Ha6YqdXC3c2ejfz9/dQz5+fy/io6xazzDxMz2jWzGqdF7rHuc=" . . "2021-12-16T19:34:23.681956"^^ . .